No Data
No Data
Psychedelic Stocks Mixed as FDA Comments on MDMA Therapy
'Top Federal Drug Official Says There's 'Tremendous Excitement' Around Psychedelic Medicine, But 'It's Not Magic'' - Marijuana Moment
'Top Federal Drug Official Says There's 'Tremendous Excitement' Around Psychedelic Medicine, But 'It's Not Magic'' - Marijuana Moment
COMPASS Pathways(CMPS.US) 10% Shareholder Sells US$246.57K in Common Stock
$COMPASS Pathways(CMPS.US)$ 10% Shareholder Malievskaia Ekaterina sold 31,207 shares of common stock on May 20, 21, 2024 at an average price of $7.901 for a total value of $246.57K. This transaction i
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Exploring Compass Pathways' (CMPS) After-Market Rally: Unveiling The Catalysts
During Thursday's after-market trading session, Compass Pathways plc (NASDAQ: CMPS) saw a notable spike in its shares. The stock was down 3.50% during the regular session, closing the extended session at $7.99, before closing at $8.34, up 4.38%. Given the absence of any significant news throughout the CMPS share movement, it's probable that current occurrences will ...
COMPASS Pathways Plc (NASDAQ:CMPS) Q1 2024 Earnings Call Transcript
No Data